Table 1 Summary of the pathological classification of glioma in index patients
From: Downregulation of CDKN2A and suppression of cyclin D1 gene expressions in malignant gliomas
Glioma classification | WHO grade | Male/Female | N | Age(years) |
|---|---|---|---|---|
Pilocytic Astrocytoma(PA) | I | 3/1 | 4 | 27.1 ± 10.3 |
Astrocytoma(A) | II | 11/5 | 16 | 47.2 ± 6.9 |
Oligodendroglioma(O) | II | 3/3 | 6 | 54.8 ± 9.2 |
Low-Grade glioma |  | 17/9 | 26 | 48.3 ± 9.1 |
Anaplastic Astrocytoma(AA) | III | 6/3 | 9 | 44.2 ± 10.7 |
Anaplastic Oligodendroglioma(AO) | III | 4/1 | 5 | 47.9 ± 5.4 |
Glioblastoma Multiforme(GBM) | IV | 16/5 | 21 | 55.3 ± 9.5 |
High-Grade glioma |  | 26/9 | 35 | 52.2 ± 9.8 |